Divis Laboratories Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Divis Laboratories Quarterly Results    (DIVI)

Here are the latest quarterly results of Divis Laboratories. For more details, see the Divis Laboratories financial fact sheet and Divis Laboratories share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Divis Laboratories Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-19
3
Jun-19
3
Sep-19
3
Dec-19
3
Mar-20
3
Jun-20
3
Sep-20
3
Dec-20
8-Qtr Chart
Click to enlarge
Net Sales Rs m12,56411,39914,45613,90513,76217,10017,13816,565 
Other income Rs m417316470403765179136197 
Turnover Rs m12,98211,71614,92614,30814,52817,27817,27416,762 
Expenses Rs m8,4537,6139,5508,9369,27610,1109,8149,780 
Gross profit Rs m4,1113,7864,9064,9694,4866,9907,3246,785 
Depreciation Rs m423438459467495560609680 
Interest Rs m1338164212 
Profit before tax Rs m4,1043,6614,8794,8894,7526,6076,8506,300 
Tax Rs m1,2109881,3111,2828341,6851,7171,687 
Profit after tax Rs m2,8942,6743,5683,6073,9184,9235,1334,612 
Gross profit margin %32.733.233.935.732.640.942.741.0 
Effective tax rate %29.527.026.926.217.625.525.126.8 
Net profit margin %23.023.524.725.928.528.830.027.8 
Diluted EPS Rs 10.9 10.1 13.4 13.6 14.8 18.5 19.3 17.4  
Diluted EPS (TTM) Rs 50.2 50.2 48.7 48.0 51.9 60.3 66.2 70.0  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Divis Laboratories 3QFY21 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   ALEMBIC  VENUS REMEDIES  PROCTER & GAMBLE HEALTH  AUROBINDO PHARMA  UNICHEM LAB  

Compare DIVIS LABORATORIES With:   ALEMBIC  VENUS REMEDIES  PROCTER & GAMBLE HEALTH  AUROBINDO PHARMA  UNICHEM LAB  

Compare DIVIS LABORATORIES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 257 Points Higher; Tata Steel & Hindalco Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Views on news

DIVIS LABORATORIES Announces Quarterly Results (3QFY21); Net Profit Up 27.9% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 27.9% YoY). Sales on the other hand came in at Rs 17 bn (up 19.1% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (1QFY21); Net Profit Up 84.1% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 84.1% YoY). Sales on the other hand came in at Rs 17 bn (up 50.0% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

More Views on News

Most Popular

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away? (Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

This Fund Manager Has Taken the World by Storm. Will You Invest With Her? (Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


May 7, 2021 (Close)

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES - ADCOCK INGRAM COMPARISON

COMPARE DIVIS LABORATORIES WITH

MARKET STATS